Home > Insider Trading > Filing (0001209191-14-042678)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1123979	Senomyx Inc	SNMX	Services-Commercial Physical & Biological Research (8731)	330843840

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1360670	Sharon Wicker	C/O Senomyx, Inc. 4767 Nexus Centre Drive San Diego CA 92121	Sr Vp & Chf Comm Dvlpt Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-06-19	14,582	$2.11	55,274	No	4	M	Direct
Common Stock	Acquisiton	2014-06-19	15,502	$3.21	70,776	No	4	M	Direct
Common Stock	Acquisiton	2014-06-19	10,850	$2.50	81,626	No	4	M	Direct
Common Stock	Acquisiton	2014-06-19	9,166	$3.30	90,792	No	4	M	Direct
Common Stock	Disposition	2014-06-19	25,432	$9.00	65,360	No	4	S	Direct
Common Stock	Disposition	2014-06-19	15,502	$9.21	49,858	No	4	S	Direct
Common Stock	Disposition	2014-06-19	9,166	$9.30	40,692	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to buy)	Disposition	2014-06-19	14,582	$0.00	14,582	$2.11
Common Stock	Stock option (right to buy)	Disposition	2014-06-19	15,502	$0.00	15,502	$3.21
Common Stock	Stock option (right to buy)	Disposition	2014-06-19	10,850	$0.00	10,850	$2.50
Common Stock	Stock option (right to buy)	Disposition	2014-06-19	9,166	$0.00	9,166	$3.30

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
72,918	2023-04-14	No	4	D	Direct
7,753	2019-02-15	No	4	D	Direct
10,850	2020-02-15	No	4	D	Direct
59,585	2022-02-14	No	4	D	Direct

Footnotes

Reported transaction occurred pursuant to Rule 10B5-1 Plan.
In addition to the 40,692 shares of Common Stock beneficially owned, the Reporting Person also holds outstanding options to purchase 595,518 shares of Common Stock.
1/4th of the shares vest one year after the date of grant of 4/15/13. 1/48th of the shares vest monthly thereafter over the next 3 years until fully vested on 4/15/17.
The shares subject to the option are fully vested.
1/4th of the shares vest one year after the date of grant of 2/15/12. 1/48th of the shares vest monthly thereafter over the next 3 years until fully vested on 2/15/16.